CAT No: CP26139
CAS No:102185-35-3
Synonyms/Alias:2-((tert-Butoxycarbonyl)amino)-3,3-dimethylbutanoicacid;Boc-Dl-Tle-Oh;102185-35-3;N-Boc-t-butylglycine;2-tert-butoxycarbonylamino-3,3-dimethyl-butyricacid;SBB057601;2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid;2-{[(tert-butoxy)carbonyl]amino}-3,3-dimethylbutanoicacid;2-[(TERT-BUTOXYCARBONYL)AMINO]-3,3-DIMETHYLBUTANOICACID;boc-tbu-dl-gly-oh;boc-dl-(tbu)gly-oh;AC1NNLQY;ACMC-209yh6;AC1Q1N7T;Boc-DL-|A-tert-butyl-Gly;SCHEMBL90052;ACMC-209u66;Boc-DL-alpha-tert-butyl-Gly-OH;CTK8B6258;LRFZIPCTFBPFLX-UHFFFAOYSA-N;MolPort-001-793-459;ACT10783;0573AA;3,3-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoicAcid;ANW-53153
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.